HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute promyelocytic leukaemia long-term survivors: higher fatigue and greater overall symptom burden.

AbstractOBJECTIVE:
We aimed to investigate the association of fatigue with severity of other key cancer symptoms, as well as symptom interference with daily activities and outlook on life, in long-term survivors of acute promyelocytic leukaemia (APL).
METHODS:
The study sample consisted of APL survivors (n=244), with a median time from diagnosis of 14.3 years (IQR=11.1-16.9 years), previously enrolled in a long-term follow-up study. Symptom severity and symptom interference were assessed using the well-validated MD Anderson Symptom Inventory (MDASI). Fatigue was evaluated with the Functional Assessment of Chronic Illness Therapy-Fatigue questionnaire.
RESULTS:
Higher fatigue burden was associated with increased affective symptoms, memory problems, drowsiness, sleep disturbances, shortness of breath and pain. Higher levels of fatigue were also associated with higher scores across all interference items of the MDASI. Overall, symptoms interfered most with mood, but among APL survivors with high levels of fatigue, symptoms interfered most with enjoyment of life. Multivariable regression analysis confirmed the independent association between fatigue and all symptom severity items of the MDASI.
CONCLUSIONS:
The current findings show that long-term APL survivors who report higher fatigue also experience a greater overall symptom burden and a substantial impact on performance of daily activities. Further studies are needed to examine whether interventions aimed at reducing fatigue could also reduce overall symptom burden.
AuthorsKathrin Sommer, Marco Vignetti, Francesco Cottone, Massimo Breccia, Ombretta Annibali, Mario Luppi, Tamara Intermesoli, Erika Borlenghi, Paola Carluccio, Francesco Rodeghiero, Francesco Fabbiano, Claudio Romani, Marco Sborgia, Bruno Martino, Monica Crugnola, Fabio Efficace
JournalBMJ supportive & palliative care (BMJ Support Palliat Care) Vol. 12 Issue 2 Pg. 182-186 (Jun 2022) ISSN: 2045-4368 [Electronic] England
PMID32680895 (Publication Type: Journal Article)
Copyright© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Topics
  • Fatigue (epidemiology, etiology)
  • Follow-Up Studies
  • Humans
  • Leukemia, Promyelocytic, Acute
  • Severity of Illness Index
  • Sleep Wake Disorders
  • Survivors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: